Canadian pharmaceutical company Apotex Health Corp. (TSE: APTX) has reported a net loss in its first ...
TORONTO - Apotex Health Corp. says it had a net loss of $38.3 million in its first quarter as its revenue fell from the same period last year. The pharmaceutical company says the result compared...
– Canada Delivers 11% Revenue Growth in Q1
U.S. President Donald Trump has set his sights on generic drug imports into the U.S. amid the latest bout of trade tensions between Canada and the U.S. In a social media post, Trump said...
TORONTO , July 16, 2026 /PRNewswire/ -- Apotex Health Corp ("Apotex" or the "Company") (TSX: APTX) today announced the successful completion of an amended and restated credit agreement ("Amended...
TORONTO , July 8, 2026 /CNW/ - Apotex Health Corp. ("Apotex") (TSX: APTX) today announced the U.S. launch of four product configurations of its generic equivalents of Infuvite ® Pediatric...
TORONTO , July 8, 2026 /PRNewswire/ - Apotex Health Corp. ("Apotex") (TSX: APTX) today announced the U.S. launch of four product configurations of its generic equivalents of Infuvite ® ...
TORONTO , July 1, 2026 /PRNewswire/ - Apotex Health Corp. ("Apotex") (TSX: APTX), the largest Canadian-based pharmaceutical company, today announced the closing of its previously announced strategic...
TORONTO , June 30, 2026 /CNW/ - Apotex Health Corp. ("Apotex" or the "Company") (TSX: APTX), the largest Canadian-based global health company, today announced it is the first to receive Health Canada's...
TORONTO , June 30, 2026 /PRNewswire/ - Apotex Health Corp. ("Apotex" or the "Company") (TSX: APTX), the largest Canadian-based global health company, today announced it is the first to receive Health...